Core Viewpoint - DuPont's stock rose over 2% pre-market, reaching $48, following the announcement of its Q4 2025 earnings, which met expectations and showed positive growth in the healthcare sector [1] Financial Performance - DuPont reported net sales of $1.69 billion for Q4 2025, aligning with market expectations [1] - Adjusted earnings per share (EPS) were $0.46, surpassing analyst expectations of $0.43, driven by growth in the healthcare segment and business restructuring [1] Future Outlook - For 2026, DuPont projects adjusted EPS to be between $2.25 and $2.30, with net sales expected to range from $7.08 billion to $7.14 billion [1] - Analyst expectations for 2026 are slightly lower, with projected EPS at $2.14 and net sales at $7.06 billion [1]

格隆汇2月10日丨心动公司(02400.HK)公告，2月10日耗资198万港元回购2.4万股，每股回购价81.75-84.3 港元。 ...

格隆汇2月10日丨滉达富控股(01348.HK)宣布，倪子轩已获委任为公司联席公司秘书，自2026年2月10日 起生效。 ...

美银将卡特彼勒的目标价从735美元上调至825美元，维持"买入"评级。(格隆汇) ...

格隆汇2月10日丨宜明昂科-B(01541.HK)公告，于2026年2月10日，公司与借款人田文志订立贷款协议， 据此，公司同意向借款人提供本金为人民币1372万元的贷款。 ...

Core Viewpoint - The company is making steady progress in the development and commercialization of its robotic-related products, with various protective items already launched and others in testing phases [1] Group 1: Product Development - The company has successfully commercialized protective products such as flexible joint protectors and protective gloves [1] - High molecular weight polyethylene fiber transmission tendons and skin suits/gloves have been sent for testing to several leading domestic and international companies, with ongoing iterations [1] - The electronic skin suits and gloves are focusing on sensor integration and functionality validation, with pilot production line construction progressing as planned [1]

格隆汇2月10日丨连连数字(02598.HK)公告，2月10日耗资171万港元回购26.1万股。 ...

Core Viewpoint - The company emphasizes that the clawdbot has no direct impact on its existing business and is committed to advancing its "Huikang Cloud Strategic Planning" to enhance product innovation and system reliability [1] Group 1: Business Strategy - The company will focus on continuous product innovation and the deepening of core system applications, particularly HI-HIS, to improve system reliability and data security [1] - The company aims to optimize implementation processes and build a standardized delivery system to ensure efficient project execution [1] - Collaboration with ecosystem partners will be prioritized to integrate medical scene demands with cutting-edge technology, accelerating the transformation of R&D results [1] Group 2: Competitive Advantage - The company plans to strengthen its product technology barriers and core competitive advantages through enhanced development support and operational knowledge accumulation [1] - A standardized toolchain will be established to improve the professional capabilities of the delivery team, alongside a rapid deployment mechanism to address short-term market challenges [1] Group 3: Market Outlook - The company expresses confidence in the broad prospects of the medical information industry and the ongoing core demands of clients [1] - With enhanced product technology strength, improved project delivery efficiency, and innovative applications in the medical AI field, the company will continue to deepen its focus on the medical information sector [1] - The company aims to explore new models and paths for smart hospital construction in collaboration with various medical institutions, contributing to high-quality development in healthcare [1]

格隆汇2月10日丨凯盛新材(301069.SZ)在互动平台表示，凯盛新材作为国内领先的PEKK生产商，我们 的产品已经广泛应用于通用型材、喷涂、新能源汽车、军工航空航天等多个领域，并且正在积极向电子 信息（半导体）、康复医疗器械、机器人等新兴市场拓展。公司PEKK产品产能为1000吨/年，目前可以 满足市场需求。 ...

Core Viewpoint - The company is making steady progress on its 4,800-ton ultra-high molecular weight polyethylene fiber project, with some production lines already established and achieving stable output, receiving high recognition from downstream customers [1] Group 1: Project Development - The project is expected to enter a steady ramp-up phase by 2026, with the company planning to release production capacity in stages based on line adjustments, process optimization, market expansion, and order acquisition [1] - The company aims to fully release the project's production capacity by the end of 2026, enhancing its supply capability and market competitiveness in the high-end fiber sector [1] Group 2: Market Applications - The high-end fiber products will support various applications, including safety protection, marine rope nets, commercial aerospace, robotics, and advanced composite materials [1]